Cargando…
Urinary semaphorin 3A as an early biomarker to predict contrast-induced acute kidney injury in patients undergoing percutaneous coronary intervention
Contrast-induced acute kidney injury (CI-AKI) is a serious complication of diagnostic coronary angiograph and percutaneous coronary intervention (PCI). However, the exact pathophysiological mechanisms underlying CI-AKI development are largely unknown. The present study examined whether urinary semap...
Autores principales: | Ning, Li, Li, Zhiguo, Wei, Dianjun, Chen, Haiyan, Yang, Chao, Wu, Dawei, Wang, Yanchun, Zhang, Jingwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Associação Brasileira de Divulgação Científica
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5856432/ https://www.ncbi.nlm.nih.gov/pubmed/29513790 http://dx.doi.org/10.1590/1414-431X20176487 |
Ejemplares similares
-
Urinary interleukin-18 as an early indicator to predict contrast-induced nephropathy in patients undergoing percutaneous coronary intervention
por: HE, HAIYAN, et al.
Publicado: (2014) -
Midkine: A Novel and Early Biomarker of Contrast-Induced Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Interventions
por: Malyszko, Jolanta, et al.
Publicado: (2015) -
Increased urinary adiponectin level is associated with contrast-induced nephropathy in patients undergoing elective percutaneous coronary intervention
por: Zhang, Jun-yi, et al.
Publicado: (2019) -
Effects of probucol on contrast-induced acute kidney injury in patients undergoing percutaneous coronary intervention
por: Wang, Yong, et al.
Publicado: (2019) -
Contrast-Induced Acute Kidney Injury in Patients on SGLT2 Inhibitors Undergoing Percutaneous Coronary Interventions: A Propensity-Matched Analysis
por: Hua, Rui, et al.
Publicado: (2022)